HF Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
HF Advisory Group's LLY Position: Q2 2026 in Review
HF Advisory Group increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $284K and bringing the position to 2,246 shares worth $2.69M. The position accounts for 0.83% of the portfolio, ranked #47.
HF Advisory Group first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 893 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- HF Advisory Group held 2,246 shares of Eli Lilly worth $2.69M as of Q2 2026.
- HF Advisory Group bought 278 Eli Lilly shares in Q2 2026, an estimated $284K.
- Eli Lilly made up 0.83% of HF Advisory Group's portfolio in Q2 2026, its #47 holding.
- HF Advisory Group first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- 893 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on HF Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.